MedTrace Logo

An Observational Study in Children and Adults With Stargardt Disease

NCT06591806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-08-28

No results posted yet for this study

Summary

This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.

Conditions

Sponsors & Collaborators

  • AAVantgarde Bio Srl

    lead INDUSTRY

Eligibility

Min Age
8 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-01
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States
  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06591806 on ClinicalTrials.gov